Us Bancorp \De\ Becton Dickinson & CO Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Becton Dickinson & CO stock. As of the latest transaction made, Us Bancorp \De\ holds 83,383 shares of BDX stock, worth $19.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

83,383

Previous 74,193 12.39%

Holding current value

$19.5 Million

Previous $17.3 Million 15.94%

% of portfolio

0.03%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$221.47 - $242.41 $2.04 Million - $2.23 Million	9,190 Added 12.39%	83,383 $20.1 Million
Q2 2024 Aug 06, 2024	SELL	$225.07 - $246.17 $263,782 - $288,511	-1,172 Reduced 1.56%	74,193 $17.3 Million
Q1 2024 May 07, 2024	SELL	$233.45 - $247.73 $1.76 Million - $1.87 Million	-7,529 Reduced 9.08%	75,365 $18.6 Million
Q4 2023 Feb 09, 2024	BUY	$232.24 - $267.23 $1.32 Million - $1.52 Million	5,678 Added 7.35%	82,894 $20.2 Million
Q3 2023 Nov 03, 2023	SELL	$254.9 - $283.59 $1.12 Million - $1.25 Million	-4,395 Reduced 5.39%	77,216 $20 Million
Q2 2023 Aug 09, 2023	SELL	$238.39 - $265.32 $840,563 - $935,518	-3,526 Reduced 4.14%	81,611 $21.5 Million
Q1 2023 May 09, 2023	BUY	$229.71 - $259.35 $190,659 - $215,260	830 Added 0.98%	85,137 $21.1 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $655,306 - $771,243	3,002 Added 3.69%	84,307 $21.4 Million
Q3 2022 Oct 27, 2022	SELL	$51.03 - $264.23 $30,413 - $157,481	-596 Reduced 0.73%	81,305 $18.1 Million
Q2 2022 Aug 01, 2022	BUY	$234.74 - $275.42 $1.19 Million - $1.39 Million	5,049 Added 6.57%	81,901 $20.2 Million
Q1 2022 May 11, 2022	SELL	$243.64 - $270.48 $161,046 - $178,787	-661 Reduced 0.85%	76,852 $20.4 Million
Q4 2021 Feb 11, 2022	SELL	$230.08 - $250.94 $959,203 - $1.05 Million	-4,169 Reduced 5.1%	77,513 $19.5 Million
Q3 2021 Nov 10, 2021	SELL	$232.72 - $256.47 $282,056 - $310,841	-1,212 Reduced 1.46%	81,682 $20.1 Million
Q2 2021 Aug 05, 2021	BUY	$232.65 - $254.58 $1.5 Million - $1.64 Million	6,457 Added 8.45%	82,894 $20.2 Million
Q1 2021 Apr 28, 2021	SELL	$232.09 - $256.88 $506,420 - $560,512	-2,182 Reduced 2.78%	76,437 $18.6 Million
Q4 2020 Feb 04, 2021	SELL	$221.92 - $245.94 $331,326 - $367,188	-1,493 Reduced 1.86%	78,619 $19.7 Million
Q3 2020 Nov 10, 2020	SELL	$215.77 - $276.76 $535,972 - $687,471	-2,484 Reduced 3.01%	80,112 $18.6 Million
Q2 2020 Aug 07, 2020	SELL	$219.9 - $263.41 $733,366 - $878,472	-3,335 Reduced 3.88%	82,596 $19.8 Million
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $744,404 - $1.06 Million	-3,804 Reduced 4.24%	85,931 $19.7 Million
Q4 2019 Feb 04, 2020	SELL	$236.45 - $266.82 $1.38 Million - $1.56 Million	-5,842 Reduced 6.11%	89,735 $24.4 Million
Q3 2019 Nov 08, 2019	SELL	$230.58 - $256.08 $1.38 Million - $1.54 Million	-6,004 Reduced 5.91%	95,577 $24.2 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $707,637 - $800,990	-3,255 Reduced 3.1%	101,581 $25.6 Million
Q1 2019 May 08, 2019	SELL	$206.05 - $248.17 $440,328 - $530,339	-2,137 Reduced 2.0%	104,836 $26.2 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $493,194 - $621,353	-2,409 Reduced 2.2%	106,973 $24.1 Million
Q3 2018 Nov 01, 2018	SELL	$233.07 - $256.0 $1.49 Million - $1.63 Million	-6,377 Reduced 5.51%	109,382 $28.5 Million
Q2 2018 Aug 08, 2018	SELL	$208.1 - $233.85 $1.31 Million - $1.47 Million	-6,279 Reduced 5.15%	115,759 $27.7 Million
Q1 2018 May 08, 2018	BUY	$205.46 - $240.27 $3.24 Million - $3.79 Million	15,763 Added 14.83%	122,038 $26.4 Million
Q4 2017 Feb 02, 2018	BUY	$189.0 - $222.64 $500,850 - $589,996	2,650 Added 2.56%	106,275 $22.8 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $19.4 Million - $20.6 Million	103,625	103,625 $20.3 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $66.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account